Nucleoside-modified AdoMet analogues for differential methyltransferase targeting

30Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

Methyltransferases (MTases) modify a wide range of biomolecules using S-adenosyl-l-methionine (AdoMet) as the cosubstrate. Synthetic AdoMet analogues are powerful tools to site-specifically introduce a variety of functional groups and exhibit potential to be converted only by distinct MTases. Extending the size of the substituent at the sulfur/selenium atom provides selectivity among MTases but is insufficient to discriminate between promiscuous MTases. We present a panel of AdoMet analogues differing in the nucleoside moiety (NM-AdoMets). These NM-AdoMets were efficiently produced by a previously uncharacterized methionine adenosyltransferase (MAT) from methionine and ATP analogues, such as ITP and N6-propargyl-ATP. The N6-modification changed the relative activity of three representative MTases up to 13-fold resulting in discrimination of substrates for the methyl transfer and could also be combined with transfer of allyl and propargyl groups.

Cite

CITATION STYLE

APA

Cornelissen, N. V., Michailidou, F., Muttach, F., Rau, K., & Rentmeister, A. (2020). Nucleoside-modified AdoMet analogues for differential methyltransferase targeting. Chemical Communications, 56(14), 2115–2118. https://doi.org/10.1039/c9cc07807j

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free